IL33 and myeloproliferative disorder: IL-33, released by stromal and tumoral cells, has been identified as a crucial factor in the tumorigenesis of myeloproliferative neoplasms and solid tumors, including colorectal cancers, gastric cancer, and squamous cell carcinomas6,8,10,11.